GSK wins FDA approval for measles, mumps and rubella vaccine Priorix
(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has approved its Priorix vaccine for active immunisation for the prevention of measles, mumps and rubella in individuals of 12 months of age and older. Read More